The European Union series is designed to provide an authoritative library on the European Union ranging from general introductory texts to definitive assessments of key institutions and actors, policies and policy processes, and the role of member states.Books in the series are written by leading scholars in their fields and reflect the most upto-date research and debate. Particular attention is paid to accessibility and clear presentation for a wide audience of students, practitioners and interested general readers.The series consists of four major strands:• general textbooks • the major institutions and actors the main areas of policy the member states and the Union

No abstract

Dedicated biotechnologv jm (DBFs) have played an important role in commercializing bioikhnology. T h y ernergedjirst in the US and, a& a 5;year time lag, t h y also appeared in Europe. Faced Lenth long and costb product lead times, D M s raised money by entering into research contracts, main4 m'th large chernical and pharmaceutical companies. These cooperative research alliances have not vanhhed as biotechnolopy has matured and are more in evidence today than they were in the ear4 days of the commerciali~ation of biotechnologv. T h k paper investigates how and why large and small companies enter research collaborations, what t h y learn ?om working togeth, and the efects on European competitiveness.

No abstract

No abstract

No abstract

No abstract

No abstract